SF
PFE icon

SBK Financial’s Pfizer PFE Stock Holding History

SBK Financial’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$945K Hold
18,445
– – 1.5% 24
2022
Q3 		$807K Sell
18,445
-333
-2% -$16.2K 1.24% 27
2022
Q2 		$985K Buy
18,778
+333
+2% +$17K 1.29% 21
2022
Q1 		$955K Hold
18,445
– – 0.95% 25
2021
Q4 		$1.09M Buy
+18,445
New +$914K 0.87% 24

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SBK Financial's PFE Position: Q4 2022 in Review

SBK Financial held its Pfizer (PFE) position steady in Q4 2022 at 18,445 shares worth $945K. The position accounts for 1.5% of the portfolio, ranked #24.

SBK Financial first reported a position in PFE in Q4 2021 and has held it in 5 quarters since. The position peaked at $1.09M in Q4 2021. 3,268 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • SBK Financial held 18,445 shares of Pfizer worth $945K as of Q4 2022.
  • SBK Financial left its Pfizer share count unchanged in Q4 2022.
  • Pfizer made up 1.5% of SBK Financial's portfolio in Q4 2022, its #24 holding.
  • SBK Financial first reported a position in Pfizer in Q4 2021 and has held it in 5 quarters since.
  • SBK Financial's Pfizer position peaked at $1.09M in Q4 2021.
  • 3,268 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on SBK Financial's 13F filing for Q4 2022, filed 31 Jan 2023.